Epstein Barr Virus

Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives.
Multiple Sclerosis and the Epstein Barr Virus

Epstein-Barr virus (EBV) is a herpes virus otherwise known of as human herpesvirus 4 (HHV-4). It is most well known for causing glandular fever but research shows that EBV infection is also linked to an increased risk for various autoimmune conditions including rheumatoid arthritis, dermatomyositis and multiple sclerosis.

Read More

Overview

Latest Epstein Barr Virus News and Research

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

Epstein-Barr virus reactivation may play a role in long COVID and severe COVID-19 cases

SARS-CoV-2 test in 20 minutes with FISH

SARS-CoV-2 test in 20 minutes with FISH

Epstein-Barr virus reactivation may be the cause of long COVID symptoms

Epstein-Barr virus reactivation may be the cause of long COVID symptoms

New research uncovers substantial differences in rates of childhood cancers

New research uncovers substantial differences in rates of childhood cancers

Novel method allows rapid, absolute quantification of viral nucleic acids

Novel method allows rapid, absolute quantification of viral nucleic acids

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

Corilagin: could a plant compound used in Chinese herbal medicine help prevent COVID-19?

Neurocognitive symptoms persist 6 months post-infection with long COVID

Neurocognitive symptoms persist 6 months post-infection with long COVID

Class I HLA alleles shape CD8+ T cell repertoire in SARS-CoV-2 infection

Class I HLA alleles shape CD8+ T cell repertoire in SARS-CoV-2 infection

Curcumin nanosystems could be powerful COVID-19 therapeutics

Curcumin nanosystems could be powerful COVID-19 therapeutics

Coronavirus deranges the immune system in complex and deadly ways

Coronavirus deranges the immune system in complex and deadly ways

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

COVID-19 has transformed the world of vaccines

COVID-19 has transformed the world of vaccines

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Specific genetic target could help explain the variation in COVID-19 effects

Specific genetic target could help explain the variation in COVID-19 effects

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Pomegranate extract could inhibit the virus that causes COVID-19

Pomegranate extract could inhibit the virus that causes COVID-19